•
Sep 30, 2021

Enfusion Q3 2021 Earnings Report

Enfusion's Q3 2021 results were announced, with revenue up 46.8% year-over-year.

Key Takeaways

Enfusion reported strong Q3 2021 results, with total revenue reaching $29.0 million, a 46.8% increase year-over-year. The growth was driven by new client signings and expansion from existing clients. Net income was $3.3 million.

Total revenue grew to $29.0 million, up 46.8% year over year.

Platform Subscriptions revenue grew to $27.1 million, up 48.4% year over year.

Managed Services revenue grew to $1.9 million, up 61.5% year over year.

Net income was $3.3 million compared to net income of $5.6 million during the same period in the prior year.

Total Revenue
$29M
Previous year: $19.8M
+46.8%
EPS
$0.05
Previous year: $0.0871
-42.6%
Annual Recurring Revenue
$120M
Previous year: $120M
+0.0%
Net Dollar Retention excl. Churn
125.9%
Net Dollar Retention incl. Churn
122%

Enfusion

Enfusion

Enfusion Revenue by Segment

Forward Guidance

Enfusion provided guidance for Q4 2021, expecting revenue between $30.0 million and $30.5 million, and income from operations between ($293) million and ($294) million.